Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research

Non-Invasive Prenatal Testing (NIPT)Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research PR Newswire NEW YORK, January 6, 2014 According to a new market report published by Transparency Market Research, "Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global NIPT market was valued at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019, to reach an estimated value of USD 3.62 billion in 2019. Browse the full report with complete TOC at http://www.transparencymarketresearch.com/noninvasive-prenatal- diagnostics-market.html The market for non-invasive prenatal testing is evolving rapidly due the advantages it offers over the conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling (CVS). These advantages include safety, accuracy, and no risk of miscarriage. An NIPT is a non-invasive genetic screening test for the common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.) observed in the fetuses of high risk pregnant women (above the age of 35 years).